AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Pharmaceutical Companies and the Oral Agent Moova Lapplin
This chapter discusses the different approaches of pharmaceutical companies like Amgen, Silence Therapeutic, and Eli Lilly in treating heart disease. It focuses on Eli Lilly's successful phase one study of their oral agent, Moova Lapplin, which could reduce elevated lipoprotein A levels by more than 50%.